Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Anixa Biosciences Inc from Q3 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Anixa Biosciences Inc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q3 2021 to Q2 2025.
  • Anixa Biosciences Inc Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Jul 2025 was $63K, a 4.55% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $63K -$3K -4.55% 31 Jul 2025 10-Q 10 Sep 2025
Q1 2025 $63K 30 Apr 2025 10-Q 28 May 2025
Q4 2024 $63K 31 Jan 2025 10-Q 11 Mar 2025
Q3 2024 $66K 31 Oct 2024 10-K 10 Jan 2025
Q2 2024 $66K 31 Jul 2024 10-Q 06 Sep 2024
Q3 2022 $65K -$4.47K -6.44% 31 Oct 2022 10-K 04 Jan 2023
Q2 2022 $65K 31 Jul 2022 10-Q 09 Sep 2022
Q1 2022 $70K 30 Apr 2022 10-Q 10 Jun 2022
Q4 2021 $70K 31 Jan 2022 10-Q 11 Mar 2022
Q3 2021 $69.5K 31 Oct 2021 10-K 04 Jan 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.